Assenagon Asset Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.8K | Hold |
10,062
| – | – | ﹤0.01% | 1116 |
|
|
2025
Q1 | $76.2K | Sell |
10,062
-123,198
| -92% | -$933K | ﹤0.01% | 1115 |
|
|
2024
Q4 | $1.62M | Sell |
133,260
-1,776
| -1% | -$21.6K | ﹤0.01% | 980 |
|
|
2024
Q3 | $2.26M | Buy |
135,036
+20,841
| +18% | +$349K | ﹤0.01% | 905 |
|
|
2024
Q2 | $1.99M | Buy |
+114,195
| New | +$1.99M | ﹤0.01% | 883 |
|
|
2023
Q4 | – | Sell |
-609,106
| Closed | -$5.51M | – | 1363 |
|
|
2023
Q3 | $5.51M | Buy |
609,106
+482,234
| +380% | +$4.36M | 0.02% | 529 |
|
|
2023
Q2 | $1.37M | Sell |
126,872
-94,468
| -43% | -$1.02M | ﹤0.01% | 868 |
|
|
2023
Q1 | $2.26M | Buy |
221,340
+138,330
| +167% | +$1.42M | 0.01% | 772 |
|
|
2022
Q4 | $876K | Buy |
+83,010
| New | +$876K | ﹤0.01% | 1025 |
|